R&D When metrics measure more than they improve The question to ask is not, "Are we measuring site performance?" but, "Are the metrics we collect providing actionable insights early enough?"
News Positive Ph1 results for AC Immune's NLRP3 inflammasome inhi... AC Immune has announced positive interim results from its Ph 1 study of ACI-19764 – a NLRP3 inflammasome inhibitor targeting chronic inflammation.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
